RVNC has not given specific guidance on the timeline, but the amount of clinical and analysis work to be done suggests that we’re looking at a 2025 approval and launch in the best-case scenario.
Monday is a good day to opt in.
MYL must have made its decision on Friday, but RVNC decided to wait until today to make the announcement. Happy to be wrong about my post on Friday!
Market Data 
Markets 
AI
